MYCN and neuroblastoma: Interestingly, GALNT14 higher expression significantly correlates with a worse OS in a public dataset of 88 NB samples (Tumor Neuroblastoma public - Versteeg - 88 - MAS5.0 - u133p2), either considering all NB patients (Figure 5A) or cases with no MYCN amplification (Figure 5B), which alone has a strong impact on the OS.